drug
zelebrudomide
Phase 1updated 6mo agoby $NRIX Nurix Therapeutics, Inc.
Phase 1community read0 votes
indications
indications
DLBCL
all catalysts(0)
nothing on the calendar yet
News(1)
- Nurix drops one BTK degrader as momentum builds behind Roche-partnered optionNurix’s BTK degrader zelebrudomide may have survived a clinical hold in recent years, but that hasn’t stopped the California biotech from dropping the cancer drug.fiercebiotech · 1mo ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that